Stay updated with breaking news from Hd Phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted orphan drug designation to the next generation BCMA-directed CAR T-cell therapy NXC-201 for the treatment of patients with amyloid light chain amyloidosis.
Dr Kremyanskaya discusses the results from cohort 1 of the MANIFEST trial in treatment-naïve myelofibrosis, differentiating features of pelabresib and recently approved JAK inhibitors, and next steps for the investigation of BET inhibitors in this population.
A specialised qualification can help you change career direction or gain new skills
Yale medical student Philip Adejumo will be traveling the globe this week to compete in...
Yale medical student Philip Adejumo will be traveling the globe this week to compete in...